Benzinga | Dec 7, 2021 08:01AM EST

Maxim Group Downgrades First Wave BioPharma to Hold

Maxim Group analyst Naz Rahman downgrades First Wave BioPharma (NASDAQ:FWBI) from Buy to Hold.